Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 779
Improving Geriatric Drug Safety in Underserved Practices
for
Cardiovascular Diseases
Location: Buffalo NY
Sponsor: Agency for Healthcare Research and Quality (AHRQ)
Sex: All
Age: 65+
Code: NCT00277173
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Buffalo NY, Stoney Creek, Hamilton, Toronto, Etobicoke,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Buffalo NY, Burlington, Scarborough Village, Ajax,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
for
Carcinoma, Non-Small Cell Lung
Location: Buffalo NY, Toronto, East Syracuse NY, Morgantown WV,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06868277
Phase 3, Recruiting
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
for
Acute Myeloid Leukemia/Myelodysplastic Syndrome,
Location: Buffalo NY, Tampa FL
Sponsor: Celyad Oncology SA
Sex: All
Age: 18+
Code: NCT03018405
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Maternal Smoking Cessation and Pediatric Obesity Prevention
for
Childhood Obesity, Smoking, Cigarette, Pregnancy
Location: Buffalo NY
Sponsor: State University of New York at Buffalo
Sex: Female
Age: 18 - 39
Code: NCT03514602
Recruiting
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
for
Indolent Systemic Mastocytosis,
Location: Buffalo NY, Ann Arbor MI, New York NY, Cincinnati OH,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT04910685
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Buffalo NY, Hackensack NJ, Boston MA, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase 1, Phase 2, Recruiting
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
for
Breast Carcinoma, Healthy Subject
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: Female
Age: 18+
Code: NCT03897270
Recruiting
Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT04696575
Phase 2, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Buffalo NY, Williamsville NY, Brampton, York PA, Ottawa,